Pranav Sharma
Urology · Detroit, MINPI 1174758965
Payments from drug & device makers
Across 54 payments — averaging $105.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Boston Scientific$516
- Photocure Inc$432
- Coloplast$279
- Procept Biorobotics Corporation$198
- Johnson & Johnson$132
- plus $406 from 9 others
What the payments were for
- Travel & lodging$2,00035%
- Food & beverage$2,20439%
- Education$1,50026%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 20 | $3,741 |
| Boston Scientific | 10 | $516 |
| Photocure Inc | 4 | $432 |
| Coloplast | 3 | $279 |
| Procept Biorobotics Corporation | 3 | $198 |
| Johnson & Johnson | 3 | $132 |
| Endo Pharmaceuticals Inc. | 1 | $123 |
| Coopersurgical, Inc. | 2 | $92 |
| Conmed Corporation | 1 | $52 |
| Medtronic | 2 | $41 |
| Urogen Pharma, Inc. | 1 | $24 |
| Ambu Inc. | 1 | $22 |
| AbbVie | 1 | $20 |
| Menarini Silicon Biosystems, Inc. | 1 | $18 |
| Tolmar Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,516
- DA VINCI SP$1,500
- Cysview$322
- TITAN$256
- SpaceOAR VUE System - 10mL$125
- XIAFLEX$123
- AquaBeam Robotic System$114
- RYBREVANT$103
- CARVYKTI$103
How this compares
$5,704 in reported general payments places this provider in the 65th percentile of 400 urology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 11 | $6,542 |
| Tamsulosin Hcl | 306 | $4,425 |
| Finasteride | 153 | $1,733 |
| Solifenacin Succinate | 30 | $1,143 |
| Estradiol | 16 | $903 |
| Oxybutynin Chloride | 35 | $475 |
| Potassium Citrate ErPotassium Citrate | 12 | $329 |
| Oxybutynin Chloride ErOxybutynin Chloride | 15 | $254 |
| Terazosin Hcl | 13 | $152 |
| Ciprofloxacin Hcl | 15 | $72 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Other urology in Detroit
- James PeabodyDetroit$2.1M
- Michael CherDetroit$132K
- Craig RogersDetroit$120K
- Aram LoebDetroit$112K
- David LeavittDetroit$59K
- Samantha RaffeeDetroit$28K
- Firas AbdollahDetroit$25K
- Naveen KachrooDetroit$25K
- Amit PatelDetroit$22K
- Asha JamzadehDetroit$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.